Seattle-Based Digital Prescribing Platform Xealth Secures $11 Million

By Annie Baker ● April 5, 2019

Photo: Xealth

Seattle-based digital prescribing platform company Xealth announced it has raised $11 million in Series A funding. The investors in this round include McKesson Ventures, Novartis, Philips, ResMed and existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC, and Froedtert and the Medical College of Wisconsin Health Network. With this funding round, Xealth is going to fuel the expansion of its platform to better connect patients and doctors.

ADVERTISEMENT

Xealth enables clinicians to prescribe and monitor digital healthcare content, apps, devices, and services from within the electronic health record (EHR) charting interface. And it can be integrated into a health system’s existing patient portal.

With these capabilities and the ability to onboard new digital care vendors in a fraction of the time, Xealth enables the delivery and measurement of digital care to improve patient care.

Xealth was originally incubated and launched at Providence St. Joseph Health in 2017. And the company also works with UPMC, the Froedtert and the Medical College of Wisconsin health network, Baylor Scott and White, Duke, and several other major health systems. There are more than 30 digital health solutions and over a million patient interactions that being prescribed by these partners for connecting patients with educational content, transportation, e-commerce product recommendations, meal delivery, and other services for improving health outcomes.

“With these new partners joining our existing investors and customers, Xealth will be serving virtually every sector of the health care industry—providers, payors, pharma, devices, and supply chain,” said Xealth CEO Mike McSherry. “The Xealth platform is quickly becoming the preferred ‘digital formulary.’”

Xealth’s newest investors are supporting the application of innovative digital tools to transform multiple segments of the healthcare industry. For example, ResMed has integrated sleep apnea therapy data into more than 1,000 third-party systems including hospital EHRs. This enables clinicians to access data faster and provide more immediate care and improve patient outcomes.

ResMed was an early partner of Xealth at Providence to help the care for the 40,000 Providence patients who are using CPAP machines. And physicians use CPAP data to help patients better prepare for upcoming procedures along with monitoring how well the device is working to maintain health.

“Xealth delivers a win for both patients and clinicians while driving digital engagement with patients,” added Providence St. Joseph Health chief digital officer Aaron Martin. “Clinicians can recommend apps, content, products or services directly from the EMR – dramatically expanding their tool set for improving patient care and engaging patients digitally.”